Acute transfusion reaction: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | |||
*For all reactions: | |||
**1. Stop the transfusion (at least temporaily) | |||
**2. Call the blood bank | |||
**3. Draw a new type + screen | |||
== Acute == | == Acute == | ||
#Intravascular Hemolytic Tranfusion Reaction | |||
#Intravascular Hemolytic | ##Occurs due to ABO incompatibility | ||
##ABO | ##Diagnosis | ||
## | ###Back pain, headache, hypotension, dyspnea, pulmonary edema, bleeding, renal failure | ||
## | ###Labs c/w hemolysis | ||
# | ##Treatment | ||
## | ###Stop transfusion | ||
## | ####Risk of death is proportional to amount of incompatible blood received | ||
## | ###Maintain urine output with IVF, mannitol, and furosemide as needed | ||
# | ###Treat shock with volume and vasopressors | ||
## | ###Treat coagulopathy w/ FFP | ||
#Febrile Nonhemolytic Tranfusion Reaction | |||
##Occurs in 20% of pts due to recipient Ab against donor leukocytes | |||
##Diagnosis | |||
###Fever, HA, myalgias, tachycardia, dyspnea, chest pain | |||
##Treatment | |||
###Stop tranfusion pending rule-out of hemolytic transfusion reaction | |||
###Give antipyretic | |||
###Restart transfusion once hemolytic transfusion reaction is ruled-out | |||
#Allergic Tranfusion Reaction | |||
##Occurs due to immune response to plasma proteins | |||
##Diagnosis | |||
###Symptoms range from urticaria/pruritus to bronchospasm, wheezing, anaphylaxis (rare) | |||
##Treatment | |||
###Stop transfusion until able to evaluate severity of allergic reaction | |||
###Give diphenhydramine | |||
###Restart transfusion if symptoms are mild | |||
#Transfusion-Related Acute Lung Injury (TRALI) | #Transfusion-Related Acute Lung Injury (TRALI) | ||
## | ##Due to granulocyte recruitment and degranulation within the lung | ||
## | ##More common with FFP and plt tranfusions (extremely rare with pRBC transfusion alone) | ||
# | ##Diagnosis | ||
###ARDS-like symptoms | |||
###B/l pulmonary infiltrates due to noncardiogenic pulmonary edema w/in 6h of transfusion | |||
##Treatment | |||
###Strop transfusion | |||
###Treat like ARDS | |||
###Avoid diuresis | |||
#Fluid Overload | #Fluid Overload | ||
##Split pRBCs to tranfuse more slowly (as slow as 1mL/kg/hr) | |||
#Sepsis | |||
##Most commonly due to yersinia which is able to grow easily in refrigerated blood | |||
== Delayed == | == Delayed == | ||
#Extravascular Hemolytic Tranfusion Reaction | |||
#Extravascular Hemolytic | ##Occurs days to weeks after transfusion | ||
##days | ##Hemolysis occurs in spleen, liver, and bone marrow | ||
## | ##Diagnosis | ||
## | ###Hyperbilirubinemia | ||
###Poor response to transfusion | |||
##Treatment | |||
###None necessary; rarely fatal | |||
#Graft-vs-Host | #Graft-vs-Host | ||
##in leukemia/lymphoma | ##Occurs in leukemia/lymphoma or immunocompromised | ||
## | ##Diagnosis | ||
## | ###Fever, rash, N/V | ||
###LFT abnormalities, pancytopenia | |||
##Treatment | |||
###Glucocorticoids | |||
#Hemosiderosis | #Hemosiderosis | ||
| Line 37: | Line 74: | ||
#1:5000 Transfusion-related acute lung injury (TRALI) | #1:5000 Transfusion-related acute lung injury (TRALI) | ||
#1:7000 Delayed hemolytic transfusion reaction | #1:7000 Delayed hemolytic transfusion reaction | ||
#1: 10,000 Symptomatic bacterial sepsis per pool of 5 donor units of platelets | #1:10,000 Symptomatic bacterial sepsis per pool of 5 donor units of platelets | ||
#1:40,000 Death from bacterial sepsis per pool of 5 donor units of platelets | #1:40,000 Death from bacterial sepsis per pool of 5 donor units of platelets | ||
#1:40,000 ABO-incompatible transfusion per RBC transfusion episode | #1:40,000 ABO-incompatible transfusion per RBC transfusion episode | ||
| Line 51: | Line 88: | ||
== Source == | == Source == | ||
#2/18/06 DONALDSON (adapted from Rosen) | #2/18/06 DONALDSON (adapted from Rosen) | ||
#Canadian Blood Services (Public Health Agency of Canada) | #Canadian Blood Services (Public Health Agency of Canada) | ||
Revision as of 05:55, 21 October 2011
Background
- For all reactions:
- 1. Stop the transfusion (at least temporaily)
- 2. Call the blood bank
- 3. Draw a new type + screen
Acute
- Intravascular Hemolytic Tranfusion Reaction
- Occurs due to ABO incompatibility
- Diagnosis
- Back pain, headache, hypotension, dyspnea, pulmonary edema, bleeding, renal failure
- Labs c/w hemolysis
- Treatment
- Stop transfusion
- Risk of death is proportional to amount of incompatible blood received
- Maintain urine output with IVF, mannitol, and furosemide as needed
- Treat shock with volume and vasopressors
- Treat coagulopathy w/ FFP
- Stop transfusion
- Febrile Nonhemolytic Tranfusion Reaction
- Occurs in 20% of pts due to recipient Ab against donor leukocytes
- Diagnosis
- Fever, HA, myalgias, tachycardia, dyspnea, chest pain
- Treatment
- Stop tranfusion pending rule-out of hemolytic transfusion reaction
- Give antipyretic
- Restart transfusion once hemolytic transfusion reaction is ruled-out
- Allergic Tranfusion Reaction
- Occurs due to immune response to plasma proteins
- Diagnosis
- Symptoms range from urticaria/pruritus to bronchospasm, wheezing, anaphylaxis (rare)
- Treatment
- Stop transfusion until able to evaluate severity of allergic reaction
- Give diphenhydramine
- Restart transfusion if symptoms are mild
- Transfusion-Related Acute Lung Injury (TRALI)
- Due to granulocyte recruitment and degranulation within the lung
- More common with FFP and plt tranfusions (extremely rare with pRBC transfusion alone)
- Diagnosis
- ARDS-like symptoms
- B/l pulmonary infiltrates due to noncardiogenic pulmonary edema w/in 6h of transfusion
- Treatment
- Strop transfusion
- Treat like ARDS
- Avoid diuresis
- Fluid Overload
- Split pRBCs to tranfuse more slowly (as slow as 1mL/kg/hr)
- Sepsis
- Most commonly due to yersinia which is able to grow easily in refrigerated blood
Delayed
- Extravascular Hemolytic Tranfusion Reaction
- Occurs days to weeks after transfusion
- Hemolysis occurs in spleen, liver, and bone marrow
- Diagnosis
- Hyperbilirubinemia
- Poor response to transfusion
- Treatment
- None necessary; rarely fatal
- Graft-vs-Host
- Occurs in leukemia/lymphoma or immunocompromised
- Diagnosis
- Fever, rash, N/V
- LFT abnormalities, pancytopenia
- Treatment
- Glucocorticoids
- Hemosiderosis
Transfusion Risk Ratios
- 1:10 Febrile non-hemolytic transfusion reaction per pool of 5 donor units of platelets (1 pack)
- 1:100 Minor allergic reactions (urticaria)
- 1:300 Febrile non-hemolytic transfusion reaction per unit of RBC (1 pack)
- 1:700 Transfusion-associated circulatory overload per transfusion episode
- 1:5000 Transfusion-related acute lung injury (TRALI)
- 1:7000 Delayed hemolytic transfusion reaction
- 1:10,000 Symptomatic bacterial sepsis per pool of 5 donor units of platelets
- 1:40,000 Death from bacterial sepsis per pool of 5 donor units of platelets
- 1:40,000 ABO-incompatible transfusion per RBC transfusion episode
- 1:40,000 Serious allergic reaction per unit of component
- 1: 82,000 Transmission of hepatitis B virus per unit of component
- 1:100,000 Symptomatic bacterial sepsis per unit of RBC
- 1:500,000 Death from bacterial sepsis per unit of RBC
- 1:1,000,000 Transmission of West Nile Virus
- 1:3,000,000 Transmission of HTLV per unit of component
- 1:3,100,000 Transmission of hepatitis C virus per unit of component
- 1:4,700,000 Transmission of HIV per unit of component
Source
- 2/18/06 DONALDSON (adapted from Rosen)
- Canadian Blood Services (Public Health Agency of Canada)
